BRIGHT EVIDENCE PACK / Experimental
A brain interface remains a clinical question.
Synchron says its Stentrode brain-computer interface is under clinical assessment for people with paralysis.
Canonical Bright record · JSON evidence pack · Key-facts embed
Dates and assessment
- Source published
- 2025-03-19
- Bright published
- 2026-09-09
- Substantive update
- 2026-09-10
- Evidence state
- Experimental
- Independent verification
- Not established by this source review
- Last source review
- 2026-09-10
The claim in context
The human problem
Paralysis can restrict communication and independent control.
The prior constraint
An implanted interface must be studied before its benefit is established.
AI’s actual role
Synchron reports using NVIDIA Holoscan for real-time on-device neural decoding, and its March 2025 announcement demonstrated a Holoscan-powered interface controlling lights, music, temperature and appliances through an Apple Vision Pro display. The Chiral cognitive foundation model is presented as a roadmap, not a released system.
The documented result
The company says trials are underway in the U.S. and Australia.
Why it may matter
The trial is a record of a question being tested with people.
Limitations
- Synchron calls the device investigational, says clinical benefit is unvalidated and says it has no commercial approval.
- The NVIDIA Holoscan work is company-reported and not independently evaluated. Stentrode clinical trials date from 2019 and are separate work; no trial result here is attributable to NVIDIA technology.
Original evidence
Attribution
Credit Bright AI Future and link the canonical Bright record.
- Link to the canonical Bright record.
- Keep material limitations with the claim they qualify.
- Link to the original evidence when repeating a substantive claim.
- Do not describe a source check or organization-reported result as independent verification.
Linked source material, quotations, trademarks and media remain subject to their owners’ terms. No reuse right is granted for third-party media.